Commission Regulation (EC) No 1950/2006 of 13 December 2006 establishing, in accordance with Directive 2001/82/EC of the European Parliament and of the Council on the Community code relating to veterinary medicinal products, a list of substances essential for the treatment of equidae and of substances bringing added clinical benefit (Text with EEA relevance)
Linked as:
Legal Act History
- Versión futura:
- A partir de 16/02/2013
- Versión actual:
- From
- Versiones pasadas:
- From 25/12/2006 to 16/02/2013
Document options
Extract
Commission Regulation (EC) No 1950/2006 of 13 December 2006 establishing, in accordance with Directive 2001/82/EC of the European Parliament and of the Council on the Community code relating to veterinary medicinal products, a list of substances essential for the treatment of equidae and of substances bringing added clinical benefit (Text with EEA relevance)
No longer available (Autolink)
See the full content of this document
This document cites
- Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Union procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (Text with EEA relevance)Text with EEA relevance
- 2000/68/EC: Commission Decision of 22 December 1999 amending Commission Decision 93/623/EEC and establishing the identification of equidae for breeding and production (notified under document number C(1999) 5004) (Text with EEA relevance)
- 93/623/EEC: Commission Decision of 20 October 1993 establishing the identification document (passport) accompanying registered equidae
- Directive 2004/28/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/82/EC on the Community code relating to veterinary medicinal products (Text with EEA relevance)
- Commission Regulation (EC) No 1451/2006 of 29 September 2006 amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards fluazuron, sodium nitrite and peforelin (Text with EEA relevance)
